Efficacy of peloidotherapy alone or in combination with hydrotherapy in osteoartritis

Efficacy of peloidotherapy alone or in combination with hydrotherapy in osteoartritisT. Adigüzel[1];A. Kuzu[1];B. Arsla[1];G. Hatice[1];M.Z. Karagülle[1][1]Istanbul UniversityLocalización:Boletín de la Sociedad Española de Hidrología Médica,ISSN0214-2813,Nº. Extra 1, 2018,págs.121-121Idioma:inglésTexto completo (pdf)ResumenAim of this study was to evaluate the efficacy of combined hydrotherapy and peloidotherapy compared to peloidotherapy alone in the treatment of patients with osteoarthritis.In this observational retrospective study 873 patients records who were undertaken balneolojical treatment at the Medical Ecology and Hydroclimatology Department of Istanbul Faculty of Medicine, were analysed. The diagnoses were 175 generalized OA, 338 knee OA, 44 hip OA, 138 hand OA, 59 cervical OA, 67 lomber OA and 11 foot ankle OA. In total 606 patients given ten treatment sessions of hydrotherapy (tap water, 37 °C) and peloidotherapy(42-43 °C) for 2 weeks, 5 days per week. In total 226 patients also given same treatment protocol except hydrotherapy. Evaluations were done before and after treatment by pain intensity (visual analog scale, VAS), patient's general evaluation (VAS), physician's general evaluation (VAS), Health Assessment Questionnaire (HAQ), Lequesne's Functional Index (LFI), Western Ontario and McMaster Universities Index(WOMAC), Waddell Index (WI), Cervical Disability and Pain Scale (CDPS), Shoulder Disability Questionnaire(SDQ).At the end of the combination therapy significant improvements have been found in all assessments

The effect of balneotherapy on sleep, clinical symptoms, serum ghrelin and leptin levels in fibromyalgia A randomized controlled single blind study

The effect of balneotherapy on sleep, clinical symptoms, serum ghrelin and leptin levels in fibromyalgiaA randomized controlled single blind studyS.S. Karabulut[1];F. Karaarslan[1];A. Dönmez[1];H. Gürdal[1];M.Z. Karagülle[1];N. Erdoğan[1][1]Istanbul UniversityLocalización:Boletín de la Sociedad Española de Hidrología Médica,ISSN0214-2813,Nº. Extra 1, 2018,págs.54-54Idioma:inglésTexto completo (pdf)ResumenEnglishObjectives: The aim of the study was to observe the effect of balneotherapy on sleep and clinical symptoms in patients with fibromyalgia and to investigate whether this effect is related to changes of serum ghrelin and leptin levels.Material and Method: Seventy female patients with fibromyalgia, diagnosed according to ACR 2010 criteria were enrolled in the study. Patients were randomly assigned to two groups. Seven patients from control group and eight patients from treatment group dropped out from the study with different reasons. The patients in the treatment group had thermal water bath at 38°C for 20 minutes a day, and mudpack treatment afterwards on back region at 45°C five days in a week, for two weeks. Control group did not receive any treatment. Visuel Analoge Scale, patient's global assessments, physician's global assessments (VAS), tender point count (TPC), Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), Beck Depression Inventory (BDI), Insomnia Severity Index (ISI), leptin and ghrelin were outcome measures of the study. Patients were assessed at the beginning of the study, twelfth day and at the end of the first month.Results: Improvements in outcome measures such as pain (VAS), physician's global assessments (VAS), FIQ, HAQ, BDI, and ISI was observed in treatment group at the end of the treatment. In between-group comparisons, treatment group was found to be superior for improvement TPC, HAQ, ISI and FIQ scores at the end of the treatment. Leptin levels elevated statistically significant in the treatment group.Conclusion: Findings suggests that balneotherapy improves sleep and clinical symptoms in fibromyalgia and this effect may related to elevated leptin levels

Spa Therapy for Generalized Osteoarthritis: an Open, Observational, Preliminary Study

Objectives. Open, prospective study to evaluate the effect of spa therapy on generalized osteoarthritis (GOA). Methods. Patients diagnosed as GOA were recruited from a private outpatient clinic. The treatment protocol was designed with 6 different spa modalities, 3 for each consecutive day, during 18 days. Interventions were Berthollet’s technique (local mineral water cloud application), peloidotherapy, hydrotherapy, under water /standard (dry) massage, supervised water exercise, bath in hydro-massage pool, bath in tub with hydro-jets, free immersion in mineral water pool. The primary outcome was a clinically relevant improvement in 50% of patients at the end of the treatment. Statistical analyses were based on intention-to-treat method. Health care providers were blinded to the study. Results. Ninety nine patients were included between March 7th-April 29th 2011 and all were analyzed for the primary outcome. Clinically relevant improvement was observed in 61% of the patients at the end of the treatment, and 68% at the 8th month. Patient acceptable symptom state was achieved in 33% of the patients at the 3rd week and 75% at the 8th month and Outcome Measures in Rheumatology-Osteoarthritis Research Society International Criteria (OMERACT-OARSI criteria) response in 41% of the patients at the 3rd week and 19% at the 8th month. Improvement was also observed in other judgment criteria evaluating pain, function and quality of life and continued until the 8th month for some of the parameters. No serious adverse effect was observed. Conclusions. Spa treatment may improve the clinical status of patients with GOA and seems to be well tolerated

Long-term efficacy of spa therapy in patients with rheumatoid arthritis

Our previous crossover randomized trial suggested that spa therapy added to usual pharmacotherapy provides benefits that lasted 6 months over pharmacotherapy alone in rheumatoid arthritis patients. We now extend, and report the long-term results of that study. In the crossover trial, patients were randomized to spa therapy first group or control first group (first assignment, period 1, 6 months); after this period and washout phase (9 months), they crossed over to the other arm (second assignment, period 2, 6 months). In this long-term study, we now analyze the 15-month results of the first assignment, and 12-month results of the second assignment in the opposite side with a 6-month extension of the follow-up period. The clinical outcome measures were pain, patient and physician global assessment, Health Assessment Questionnaire, and Disease Activity Score-28. The 15-month results of first assignment revealed no statistically significant differences between the groups in any of the efficacy outcomes (p > 0.05 for all). The 12-month results for the second assignment after crossover revealed a statistically significant decrease between the groups regarding the patient global assessment scores (p = 0.016), physician global assessment scores (p = 0.003) and swollen joints counts (p = 0.030); however, no statistically significant difference was found between the groups in any of the other efficacy outcomes (p > 0.05 for all). The short- and medium-term beneficial effects of the 2-week spa therapy added to the usual pharmacotherapy observed through the initial 6-month evaluation period may be maintained mildly to moderately to the 12-month mark in rheumatoid arthritis patients receiving conventional disease-modifying antirheumatic drugs. Further studies with a larger sample size are needed for the confirmation of the study results